FA
GILD icon

Forefront Analytics’s Gilead Sciences GILD Stock Holding History

Forefront Analytics’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-4,051
Closed -$251K – 67
2022
Q2 		$251K Buy
4,051
+314
+8% +$19.4K 0.12% 47
2022
Q1 		$221K Buy
3,737
+175
+5% +$11.2K 0.08% 52
2021
Q4 		$261K Buy
3,562
+122
+4% +$8.4K 0.09% 48
2021
Q3 		$243K Sell
3,440
-825
-19% -$58K 0.09% 51
2021
Q2 		$294K Buy
4,265
+430
+11% +$28.7K 0.12% 46
2021
Q1 		$244K Sell
3,835
-553
-13% -$35.7K 0.1% 47
2020
Q4 		$256K Buy
+4,388
New +$265K 0.11% 49
2020
Q3 		– Sell
-2,753
Closed -$212K – 58
2020
Q2 		$212K Buy
2,753
+2,368
+615% +$181K 0.13% 49
2020
Q1 		$28.8K Buy
+385
New +$26.6K 0.02% 74

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Forefront Analytics's GILD Position: Q3 2022 in Review

Forefront Analytics sold out of Gilead Sciences (GILD) in Q3 2022, closing a stake of 4,051 shares — an estimated $251K sold.

Forefront Analytics first reported a position in GILD in Q1 2020 and held it in 9 quarters. The position peaked at $294K in Q2 2021. 1,602 funds tracked by Wall St. Rank hold GILD as of Q3 2022.

  • Forefront Analytics reported no remaining Gilead Sciences position as of Q3 2022 after selling out during the quarter.
  • Forefront Analytics sold 4,051 Gilead Sciences shares in Q3 2022, an estimated $251K.
  • Forefront Analytics first reported a position in Gilead Sciences in Q1 2020 and held it in 9 quarters.
  • Forefront Analytics's Gilead Sciences position peaked at $294K in Q2 2021.
  • 1,602 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2022.

Based on Forefront Analytics's 13F filing for Q3 2022, filed 14 Nov 2022.